Most work in the area of brain disease research focuses on neuronal mechanisms of toxicity. However, gliacomprise the most abundant class of cells in the nervous system and subserve important roles inneurotransmitter uptake, ammonia detoxification and other critical processes. Although astrocytes appear tobe in a primary position to affect brain function in pathological conditions, little is known about the functionalrole of these cells in disease states. Mutations in the gene encoding the astrocyte-specific intermediatefilament, glial fibrillary acidic protein (GFAP), cause Alexander disease, a typically childhood disorder thatmanifests with seizures and severe white matter pathology. Dysmyelination is accompanied by theformation of GFAP-rich inclusions in astrocytes termed Rosenthal fibers. The presence of GFAP in theseaggregates and the observation that overexpression of GFAP in mouse astrocytes produces a severeneurological syndrome and Rosenthal fiber formation has led to the hypothesis that Alexander disease isproduced by a dominant gain of function mechanism, perhaps related to abnormal aggregation of GFAP. Totest this hypothesis and create a1 model of Alexander disease, we have expressed normal and mutantversions of GFAP in Drosophila. We find that overexpression of GFAP in the Drosophila retina and glialeads to formation of numerous GFAP-containing, Rosenthal-fiber like inclusion bodies. Inclusion bodyformation is accompanied by degeneration in the retina. In this pilot proposal we will optimize the retinaldegeneration phenotype for use in genetic screening experiments. We will then perform a limited preliminaryscreen to evaluate the utility of the retinal degeneration phenotype and to identify genetic modifiers of GFAPtoxicity.Relevance: Although nonneuronal (or glial) cells are important in normal brain function, their role in diseasestates is largely unknown. We have created a model a rare, devastating disorder called Alexander disease,to explore the role of glia in neurological diseases. A prominent feature of Alexander disease, and of our fruitfly model of the disoder, is the formation of insoluble protein aggregates. More common disorders likeAlzheimer's disease and Parkinson's disease also have abnormal protein aggregates. Thus, our work mayhave important implications for understanding and therapy of these diseases as well.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
2P01NS042803-06A2
Application #
7555749
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
2008-09-20
Project End
2010-06-30
Budget Start
2008-09-20
Budget End
2009-06-30
Support Year
6
Fiscal Year
2008
Total Cost
$599,850
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Sosunov, Alexander; Olabarria, Markel; Goldman, James E (2018) Alexander disease: an astrocytopathy that produces a leukodystrophy. Brain Pathol 28:388-398
Moody, Laura R; Barrett-Wilt, Gregory A; Sussman, Michael R et al. (2017) Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease. J Biol Chem 292:5814-5824
Sosunov, Alexander A; McKhann 2nd, Guy M; Goldman, James E (2017) The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Acta Neuropathol Commun 5:27
Wang, Liqun; Hagemann, Tracy L; Messing, Albee et al. (2016) An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. J Neurosci 36:1445-55
Heaven, Michael R; Flint, Daniel; Randall, Shan M et al. (2016) Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease. J Proteome Res 15:2265-82
Wang, Liqun; Hagemann, Tracy L; Kalwa, Hermann et al. (2015) Nitric oxide mediates glial-induced neurodegeneration in Alexander disease. Nat Commun 6:8966
Sosunov, Alexander A; McGovern, Robert A; Mikell, Charles B et al. (2015) Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities. Acta Neuropathol Commun 3:17
LaPash Daniels, Christine M; Paffenroth, Elizabeth; Austin, Elizabeth V et al. (2015) Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease. PLoS One 10:e0138132
Olabarria, Markel; Putilina, Maria; Riemer, Ellen C et al. (2015) Astrocyte pathology in Alexander disease causes a marked inflammatory environment. Acta Neuropathol 130:469-86
Minkel, Heather R; Anwer, Tooba Z; Arps, Kara M et al. (2015) Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease. Glia 63:2285-97

Showing the most recent 10 out of 64 publications